This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 firm-fixed-price delivery order, awarded on December 18, 2024, is for the supply of APLIGRAF, a regenerative skin substitute product.
The award is not associated with a set-aside program and is part of Organogenesis' broader federal contract portfolio, which includes a $25 million single-award Indefinite Delivery Contract with the Department of Veterans Affairs (VA) Headquarters for surgical implants, a $30 million multiple-award Federal Supply Schedule contract with the VA for tissue regeneration products, and a $49.5 million multiple-award Indefinite Delivery Contract with the DLA Troop Support Medical for wound care dressings and medical supplies. These contract vehicles allow Organogenesis to provide a comprehensive range of regenerative medicine products to government healthcare programs, supporting medical treatments across military and veteran healthcare systems.
Generated 3/19/25, 9:57 AM